[HTML] cell.comFull View

[HTML][HTML] Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer

M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold… - Cell, 2020 - cell.com
KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic
response that promotes hypovascularity, immunosuppression, and resistance to chemo-and …
被引用次数：261 相关文章

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.

M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold… - Cell, 2020 - europepmc.org
SUMMARY KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a
desmoplastic response that promotes hypovascularity, immunosuppression, and resistance …

[引用][C] Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold… - Cell, 2020 - cir.nii.ac.jp
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas
Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[HTML] nih.gov

[HTML][HTML] Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

M Ruscetti, JP Morris IV, R Mezzadra, J Russell… - Cell, 2020 - ncbi.nlm.nih.gov
SUMMARY KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a
desmoplastic response that promotes hypovascularity, immunosuppression, and resistance …
[HTML] cell.com

[HTML][HTML] Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold… - Cell, 2020 - cell.com
KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic
response that promotes hypovascularity, immunosuppression, and resistance to chemo-and …
[HTML] sciencedirect.com

[HTML][HTML] Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

M Ruscetti, JP Morris IV, R Mezzadra, J Russell… - Cell, 2020 - Elsevier
KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic
response that promotes hypovascularity, immunosuppression, and resistance to chemo-and …

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold… - paper.sciencenet.cn
KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a
desmoplasticresponse that promotes hypovascularity, immunosuppression, and resistance …

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

M Ruscetti, JP Morris 4th, R Mezzadra, J Russell… - Cell, 2020 - pubmed.ncbi.nlm.nih.gov
KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic
response that promotes hypovascularity, immunosuppression, and resistance to chemo-and …
[PDF] researchgate.net

[PDF][PDF] Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

M Ruscetti, JP Morris IV, R Mezzadra, J Russell… - Cell, 2020 - researchgate.net
SUMMARY KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a
desmoplastic response that promotes hypovascularity, immunosuppression, and resistance …

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.

M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold… - Cell, 2020 - europepmc.org
SUMMARY KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a
desmoplastic response that promotes hypovascularity, immunosuppression, and resistance …